Back to
CIBC Bancorp USA Inc.
RLAY
2 quarters
Position history for
CIBC Bancorp USA Inc.'s holdings in RELAY THERAPEUTICS INC
No. CIBC Bancorp USA exited its RLAY (Relay Therapeutics) position in Q1 2026. Its Q3 2025 13F listed 14,116 shares worth $73,686. CIBC Bancorp USA already held RLAY in its Q3 2025 13F, the earliest on record, and held it in 1 quarterly 13F filing.
Final Value
$0
Final Shares
0
Total Value Change
-$73,686
Total Shares Change
-14,116
Quarter-by-Quarter History